TY - JOUR
AU1 - Elmi, Maryam
AU2 - Sequeira, Sangita
AU3 - Azin, Arash
AU4 - Elnahas, Ahmad
AU5 - McCready, David
AU6 - Cil, Tulin
AB - Background Male breast cancer (MBC) is a rare malignancy, and gender-specific treatment outcomes are currently lacking. The use of a large, multi-national surgical-outcomes database may provide a better understanding of treatment patterns and postoperative morbidity in men who undergo oncological breast surgery. Methods A retrospective cohort analysis was conducted between 2007 and 2016 using the American College of Surgeons National Surgical Quality Improvement Program database (NSQIP), examining MBC treatment patterns and postoperative complication rates. All men undergoing surgery for the treatment of invasive or in situ carcinoma of the breast were identified. Clinical characteristics, demographics, and surgical treatment options most frequently used for this population were described. In addition, the 30-day postoperative complication rates in the surgical treatment of male breast cancer were evaluated. Results A total of 1773 MBC patients with a median age of 65 years (IQR 56–74 years) were included in this analysis. Mean body mass index (BMI) was 29.1 (IQR 25.4–33.8). In this study population, 177 (10.0%) had a diagnosis of in situ breast cancer, while the remaining 1596 (90.0%) had invasive disease. While most men underwent mastectomy, 282 (15.9%) had breast-conserving surgery. There were 74 (4.2%) patients who underwent immediate breast reconstruction. In addition, 118 (6.7%) patients elected 
TI - Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database
JF - Breast Cancer Research and Treatment
DO - 10.1007/s10549-018-4830-y
DA - 2018-05-28
UR - https://www.deepdyve.com/lp/springer-journals/evolving-surgical-treatment-decisions-for-male-breast-cancer-an-0w1599bMMV
SP - 427
EP - 434
VL - 171
IS - 2
DP - DeepDyve